NCT04098094

Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases

Prevalence of Right Ventricular Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases and Its Impact on Outcomes

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Observational study in patients with chronic respiratory diseases (chronic obstructive pulmonary diseases, bronchiectasis, interstitial lung diseases, neuromuscular diseases, obesity-hypoventilation syndrome...) admitted in intensive care unit for acute respiratory failure. The main objective is to determine the prevalence of right ventricular (RV) dysfunction in this population and to analyze the impact of such a complication on outcomes (survival at day-28, duration of non-invasive or mechanical ventilation, duration of hospital stay). RV function will be assessed by echocardiography at admission, after 3 days and at discharge. Plasma NT-proBNP and troponin levels will be collected.

Detailed description

Observational study in patients with chronic respiratory diseases (chronic obstructive pulmonary diseases, bronchiectasis, interstitial lung diseases, neuromuscular diseases, obesity-hypoventilation syndrome...) admitted in intensive care unit for acute respiratory failure. Inclusion Criteria: * Chronic respiratory disease (COPD, ILD, OHS...) * Admission in ICU for acute respiratory failure * Patient's non-opposition Exclusion Criteria: * Patients \< 18 year-old * Protected patients * Pregnant women The main objective is to determine the prevalence of right ventricular (RV) dysfunction in this population and to analyze the impact of such a complication on outcomes (survival at day-28, duration of non-invasive or mechanical ventilation, duration of hospital stay). RV function will be assessed by echocardiography at admission, after 3 days and at discharge. Plasma NT-proBNP and troponin levels will be collected.

Conditions

• Acute Exacerbation of COPD
• Acute Exacerbation of Bronchiectasis
• Acute Exacerbation of Asthma
• Interstitial Lung Disease
• Neuromuscular Diseases
• Obesity Hypoventilation Syndrome
• Acute Respiratory Failure

Timeline

• Start date: 2019-09-19
• Primary completion: 2022-10-30
• Completion: 2022-10-30
• First posted: 2019-09-23
• Last updated: 2022-02-18

Locations

1 site across 1 country: France